{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T16:41:22Z","timestamp":1776184882167,"version":"3.50.1"},"reference-count":29,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2011,6,20]],"date-time":"2011-06-20T00:00:00Z","timestamp":1308528000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Emerg Medicine Australasia"],"published-print":{"date-parts":[[2011,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Aim:<\/jats:bold> We aimed to compare the relative efficacy of tropisetron and metoclopramide in treating nausea\/vomiting in undifferentiated ED patients.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We undertook a randomized, double\u2010blinded, clinical trial. Adult patients requiring treatment for nausea\/vomiting were randomly assigned to either tropisetron (5\u2003mg) or metoclopramide (10\u2003mg), by i.v. bolus. The primary end\u2010point was incidence of vomiting. Secondary end\u2010points were decrease in nausea score from baseline (0\u2013100 VAS), the requirement of \u2018rescue\u2019 anti\u2010emetics, ongoing nausea over 48\u2003h and side\u2010effects.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Fifty patients were enrolled in each group. The demographic variables, presenting complaints and nausea scores at baseline did not differ (<jats:italic>P<\/jats:italic> &gt; 0.05). By 180\u2003min, two (4.0%) and nine (18.0%) patients had vomited in the tropisetron and metoclopramide groups respectively (difference 14.0%, 95% CI 0.1\u201328.0, <jats:italic>P<\/jats:italic>= 0.05). Also, there were two and 20 episodes of vomiting respectively. Vomiting rates were 0.02 and 0.16 episodes\/person\u2010hour (difference 0.14 episodes\/person\u2010hour, 95% CI 0.07\u20130.21, <jats:italic>P<\/jats:italic> &lt; 0.001) respectively. By 60\u2003min and thereafter, the decrease in nausea score from baseline was greater (although not significantly so) in the tropisetron group. At 180\u2003min, the decreases were 47.9\u2003mm and 37.0\u2003mm respectively (difference 10.9\u2003mm, 95% CI \u22120.7\u201322.6). Five (10.0%) and 13 (26.0%) patients required a rescue anti\u2010emetic respectively (difference 16.0%, 95% CI \u22120.7\u201332.7, <jats:italic>P<\/jats:italic>= 0.07). Of patients followed up, 13\/47 (27.7%) and 20\/49 (40.8%) had ongoing nausea respectively (difference 13.2%, 95% CI \u22127.7\u201334.0, <jats:italic>P<\/jats:italic>= 0.25). The tropisetron group had less akathisia.<\/jats:p><jats:p><jats:bold>Conclusions:<\/jats:bold> Tropisetron was associated with a significantly lower vomiting rate and shows promise as an alternative anti\u2010emetic in the ED.<\/jats:p>","DOI":"10.1111\/j.1742-6723.2011.01444.x","type":"journal-article","created":{"date-parts":[[2011,6,20]],"date-time":"2011-06-20T09:37:28Z","timestamp":1308562648000},"page":"554-561","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Tropisetron versus metoclopramide for the treatment of nausea and vomiting in the emergency department: A randomized, double\u2010blinded, clinical trial"],"prefix":"10.1111","volume":"23","author":[{"given":"John","family":"Chae","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"McD Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert G","family":"Frauman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,6,20]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.2055-2335.2006.tb00606.x"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2009.00581.x"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199207000-00023"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.2165\/0003495-200868180-00004"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-98-1-86"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/0091270007312258"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-199005000-00011"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.1997.tb11474.x"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/ajem.2000.16293"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199855020-00002"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200059060-00008"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.aco.0000247340.61815.38"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199200433-00005"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03011739"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1996.tb13639.x"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1996.03268.x"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00688329"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-6723.2004.00588.x"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2005.08.017"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2346.2001.00894.x"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2004.07.446"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-3223(94)91257-2"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0736-4679(00)00297-3"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1553-2712.2008.00060.x"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/0959-8049(94)90530-4"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-6576.2002.460508.x"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/030006059602400305"},{"key":"e_1_2_7_29_2","first-page":"386","article-title":"Randomised, prospective, controlled trial comparing tropisetron with metoclopramide and placebo in controlling postoperative nausea and vomiting","volume":"50","author":"Muhammad SR","year":"2000","journal-title":"J. Pak. Med. Assoc."},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0034-70942008000100005"}],"container-title":["Emergency Medicine Australasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-6723.2011.01444.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1742-6723.2011.01444.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T21:56:15Z","timestamp":1697320575000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-6723.2011.01444.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6,20]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["10.1111\/j.1742-6723.2011.01444.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1742-6723.2011.01444.x","archive":["Portico"],"relation":{},"ISSN":["1742-6731","1742-6723"],"issn-type":[{"value":"1742-6731","type":"print"},{"value":"1742-6723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,20]]},"assertion":[{"value":"2011-06-20","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}